Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Methodology and preliminary results from the neurobiology of late-life depression study.

Steffens DC, Manning KJ, Wu R, Grady JJ, Fortinsky RH, Tennen HA.

Int Psychogeriatr. 2015 Dec;27(12):1987-97. doi: 10.1017/S1041610215001386. Epub 2015 Sep 1.

2.

Resting-state functional connectivity of antero-medial prefrontal cortex sub-regions in major depression and relationship to emotional intelligence.

Sawaya H, Johnson K, Schmidt M, Arana A, Chahine G, Atoui M, Pincus D, George MS, Panksepp J, Nahas Z.

Int J Neuropsychopharmacol. 2015 Mar 5;18(6). pii: pyu112. doi: 10.1093/ijnp/pyu112.

3.

Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.

Youssef NA, McCall WV.

Ann Clin Psychiatry. 2014 Nov;26(4):288-96. Review.

4.

Persistent delusional theme over 13 episodes of psychotic depression.

Ostergaard SD, Leadholm AK, Rothschild AJ.

Acta Neuropsychiatr. 2013 Dec;25(6). doi: 10.1017/neu.2013.33.

5.

Mechanisms of antidepressant resistance.

El-Hage W, Leman S, Camus V, Belzung C.

Front Pharmacol. 2013 Nov 22;4:146. doi: 10.3389/fphar.2013.00146. Review.

6.

Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.

Jelovac A, Kolshus E, McLoughlin DM.

Neuropsychopharmacology. 2013 Nov;38(12):2467-74. doi: 10.1038/npp.2013.149. Epub 2013 Jun 18.

7.

Challenges in the treatment of major depressive disorder with psychotic features.

Rothschild AJ.

Schizophr Bull. 2013 Jul;39(4):787-96. doi: 10.1093/schbul/sbt046. Epub 2013 Apr 18. Review.

8.

Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.

Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.

J ECT. 2013 Mar;29(1):3-12. doi: 10.1097/YCT.0b013e31826ea8c4.

9.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100. doi: 10.1038/mp.2012.93. Epub 2012 Jul 3.

10.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967. Epub 2012 Jun 11.

11.

Treatment-resistant depression: therapeutic trends, challenges, and future directions.

Al-Harbi KS.

Patient Prefer Adherence. 2012;6:369-88. doi: 10.2147/PPA.S29716. Epub 2012 May 1.

12.

Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI.

J Affect Disord. 2012 Aug;139(3):283-90. doi: 10.1016/j.jad.2012.02.007. Epub 2012 Mar 5.

13.

Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study.

Nordenskjöld A, von Knorring L, Engström I.

Depress Res Treat. 2011;2011:470985. doi: 10.1155/2011/470985. Epub 2011 Nov 3.

14.

Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, Mintun MA.

Brain Stimul. 2012 Apr;5(2):163-71. doi: 10.1016/j.brs.2011.03.001. Epub 2011 Apr 3.

15.

Regional electric field induced by electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic conductivity.

Lee WH, Deng ZD, Kim TS, Laine AF, Lisanby SH, Peterchev AV.

Neuroimage. 2012 Feb 1;59(3):2110-23. doi: 10.1016/j.neuroimage.2011.10.029. Epub 2011 Oct 18.

16.

Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.

McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS.

Depress Anxiety. 2011 Nov;28(11):973-80. doi: 10.1002/da.20885. Epub 2011 Sep 2.

17.

Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial.

Yeung WF, Chung KF, Tso KC, Zhang SP, Zhang ZJ, Ho LM.

Sleep. 2011 Jun 1;34(6):807-15. doi: 10.5665/SLEEP.1056.

18.

The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults.

Gildengers AG, Mulsant BH, Al Jurdi RK, Beyer JL, Greenberg RL, Gyulai L, Moberg PJ, Sajatovic M, ten Have T, Young RC; GERI-BD Study Group.

Bipolar Disord. 2010 Dec;12(8):851-8. doi: 10.1111/j.1399-5618.2010.00877.x.

19.

The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment.

Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM.

Psychoneuroendocrinology. 2010 Nov;35(10):1486-91. doi: 10.1016/j.psyneuen.2010.04.016. Epub 2010 Jun 16.

20.

Electroconvulsive therapy-induced mania: a case report.

Saatcioglu O, Guduk M.

J Med Case Rep. 2009 Nov 2;3:94. doi: 10.1186/1752-1947-3-94.

Supplemental Content

Support Center